NVP-BYL719 is novel and specific PI3K inhibitor.NVP-BYL719 has displayed promising results in cancer therapy and is currently under clinical trials.
For research use only. We do not sell to patients.
Name | Alpelisib(BYL719) |
---|---|
Iupac Chemical Name | 1,2-Pyrrolidinedicarboxamide, N1-[4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-, (2S)- |
Synonyms | BYL-719,NVP-BYL719 |
Molecular Formula | C19H22F3N5O2S |
Molecular Weight | 441.47 |
Smile | CC=1N=C(SC1C1=CC(=NC=C1)C(C(F)(F)F)(C)C)NC(=O)N1[C@@H](CCC1)C(=O)N |
InChiKey | STUWGJZDJHPWGZ-LBPRGKRZSA-N |
InChi | InChI=1S/C19H22F3N5O2S/c1-10-14(11-6-7-24-13(9-11)18(2,3)19(20,21)22)30-16(25-10)26-17(29)27-8-4-5-12(27)15(23)28/h6-7,9,12H,4-5,8H2,1-3H3,(H2,23,28)(H,25,26,29)/t12-/m0/s1 |
CAS Number | 1217486-61-7 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | crystalline solid |
---|---|
Purity | >98% by HPLC |
Storage | 3 years -20ºCpowder |
Solubility | 5mg/ml in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |